2025 revenue consensus $473.05M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed reports Q3 EPS ($1.75), consensus ($1.37)
- Insmed price target raised to $196 from $165 at Mizuho
- Insmed assumed with an Overweight at Cantor Fitzgerald
- INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment